The phenotypic patterns of essential hypertension are the key to identifying "high blood pressure" genes

Physiological Research

Volumn 59, Issue 6, 2010, Pages 841-857

  Korner, P I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Genotype phenotype relationship; Integrative Biology; Neural and non neural mechanisms; Stress, high salt, obesity; Systems analysis and phenotype

Indexed keywords

EID: 78651420335     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.932087     Document Type: Article

References (165)

1. ADAMS MA, BOBIK A, KORNER PI: Differential development of vascular and cardiac hypertrophy in genetic hypertension: relation to sympathetic function. Hypertension 14: 191-202, 1989.
2. ADAMS MA, BOBIK A, KORNER PI: Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension 16: 252-260, 1990.
3. AGABITI-ROSEI E, RIZZONI D, CASTELLANO M, PORTERI E, ZULLI R, MUIESAN ML, BETTONI G, SALVETTI M, MUIESAN P, GIULINI SM: Media: lumen ratio in human small resistance arteries is related to forearm minimal resistance. J Hypertens 13: 341-347, 1995.
4. ANDERSON EA, MARK AL: The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 21: 136-141, 1993.
5. AUGUSTYNIAK RA, TUNCEL M, ZHANG W, TOTO RD, VICTOR RG: Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens 20: 3-9, 2002.
6. BARANZINI SE, MUDGE J, VAN VELKINBURGH JC, KHANKHANIAN P, KHREBTUKOVA I, MILLER NE, ZHANG L, FARMER AD, BELL CJ, KIM RW, MAY GD, WOODWARD JE, CAILLIER SJ, MCELROY JP, GOMEZ R, PANDO MJ, CLENDENEN LE, GANUSOVA EE, SCHILKEY FD, RAMARAJ T, KHAN OA, HUNTLEY JJ, LUO S, KWOK PY, WU TD, SCHROTH GP, OKSENBERG JR, HAUSER SL, KINGSMORE SF: Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 464: 1351-1356, 2010.
7. BARASH Y, CALARCO JA, GAO W, PAN Q, WANG X, SHAI O, BLENCOWE BJ, FREY BJ: Deciphering the splicing code. Nature 465: 53-59, 2010.
8. BARKER DJP, GODFREY KM, OSMOND C, BULL A: The relation of fetal length, ponderal index and head circumference to blood pressure and the risk of hypertension in adult life. Paediatr Perinatal Epidemiol 6: 35-44, 1992.
9. BARTHA GT, THOMPSON RF: Cerebellum and conditioning. In: The Handbook of Brain Theory and Neural Networks. MA ARBIB (ed), MIT Press, Cambridge, 1995, pp 169-172.
10. BAUM M: Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest 79: 1104-1109, 1987.
11. BEETZ N, HARRISON MD, BREDE M, ZONG X, URBANSKI MJ, SIETMAN A, KAUFLING J, BARROT M, SEELIGER MW, VIEIRA-COELHO MA, HAMET P, GAUDET D, SEDA O, TREMBLAY J, KOTCHEN TA, KAIDUNSKI M, NÜSING R, SZABO B, JACOB H, COWLEY AWJ, BIEL M, STOLL M, LOHSE MJ, BROECKEL U, HEIN L: Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice. J Clin Invest 119: 3597-3612, 2009.
12. BENETOS A, SAFAR ME: Large arteries and sodium in hypertension. In: The Arterial System in Hypertension. ME SAFAR, MF O'ROURKE (eds), Kluwer Academic Publishers, Dordrecht, 1993, pp 195-207.
13. BENETOS A, TOPOUCHIAN J, RICARD S, GAUTIER S, BONNARDEUX A, ASMAR A, POIRIER O, SOUBRIER F, AFAR M, CAMBIEN F: Influence of angiotensin II Type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 26: 44-47, 1995.
14. BERK B, ALEXANDER R: Vasoactive effects of growth factors. Biochem Pharmacol 38: 219-225, 1989.
15. + exchange in cultured vascular smooth muscle. J Biol Chem 262: 5057-5064, 1987.
16. BJÖRNTORP P: Behavior and metabolic diseases. Int J Behav Med 3: 285-302, 1996.
17. BJÖRNTORP P, HOLM G, ROSMOND R, FOLKOW B: Hypertension and the metabolic syndrome closely related central origin? Blood Press 9: 71-82, 2000
18. BOBIK A, CAMPBELL JH: Vascular derived growth factors: cell biology, pathophysiology, and pharmacology. Pharmacol Rev 45: 1-42, 1993.
19. BOCHUKOVA EG, HUANG N, KEOGH J, HENNING E, PURMANN C, BLASZCZYK K, SAEED S, HAMILTONSHIELD J, CLAYTON-SMITH J, O'RAHILLY S, HURLES ME, FAROOQI IS: Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 463: 666-670, 2010.
20. BRANSON R, POTOCZNA N, KRAL JG, LENTES K-U, HOEHE MR, HORBER FF: Binge eating as major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 348: 1096-1104, 2003.
21. BRAY GA, YORK DA: Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59: 719-809, 1979.
22. BROD J: Essential hypertension: haemodynamic observations with a bearing on its pathogenesis. Lancet 2: 773-778, 1960.
23. BROD J: Haemodynamic basis of acute pressor reactions and hypertension. Br Heart J 25: 227-245, 1963.
24. BROD J, FENCL V, HEJL Z, JIRKA J: Circulatory changes underlying blood pressure elevation during acute emotional stress (mental arithmetic) in normotensive and hypertensive subjects. Clin Sci 18: 269-279, 1959.
25. BURKE V, GRACEY MP, BEILIN LJ, MILLIGAN RA: Family history as a predictor of blood pressure in a longitudinal study of Australian children. J Hypertens 16: 269-276, 1998.
26. CARLSSON A: The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1: 179-186, 1988.
27. CARLSSON A: A paradigm shift in brain research. Science 294: 1021-1024, 2001
28. COATES JC, DE BONO M: Antagonistic pathways in neurons exposed to body fluid regulate social feeding in Caenorhabditis elegans. Nature 419: 925-928, 2002.
29. COLLINS F: Has the revolution arrived? Nature 464: 674-675, 2010
30. COWLEY AW: The genetic dissection of essential hypertension. Nature Rev Gen 7: 829-840, 2006.
31. COWLEY AW, MATTSON DL, LU S, ROMAN RJ: The renal medulla and hypertension. Hypertension 25: 663-673, 1995.
32. DALY MDB, HAZZLEDINE JL, UNGAR A: The reflex effects of alterations in lung volume on systemic vascular resistance in the dog. J Physiol Lond 188: 331-351, 1967.
33. DAMPNEY RAL: Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 74: 323-364, 1994.
34. DAVIDSON EH: The Regulatory Genome: Gene Regulatory Networks in Development and Evolution. Academic Press - Elsevier, Amsterdam, 2006.
35. DE BONO M, TOBIN DM, DAVIS MW, AVERY L, BARGMANN CI: Social feeding in Caenorhabditis elegans is induced by neurons that detect aversive stimuli. Nature 419: 899-903, 2002.
36. DENTON D: The Hunger for Salt. Springer Verlag, Berlin, 1982.
37. DIBONA GF, JONES SY, SAWIN LL: Renal sympathetic neural mechanisms as intermediate phenotype in spontaneously hypertensive rats. Hypertension 27: 626-630, 1996.
38. DZAU VJ, GIBBONS GH: Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension. Am J Cardiol 60: 99I-103I, 1987.
39. DZAU VJ, GIBBONS GH, MORISHITA R, PRATT RE: New perspectives in hypertension research: potentials of vascular biology. Hypertension 23: 1132-1140, 1994.
40. EILAM R, MALACH R, BERGMANN F, SEGAL M: Hypertension induced by hypothalamic transplantation from genetically hypertensive to normotensive rats. J Neurosci 11: 401-11, 1991.
41. ENGELMANN GL, VITULLO JC, GERRITY RG: Morphometric analysis of cardiac hypertrophy during development, maturation, and senescence in spontaneously hypertensive rats. Circ Res 60: 487-494, 1987.
42. ESLER M: The sympathetic nervous system normal blood pressure control, in aging, and in hypertension. In: Hypertension: Pathophysiology, Diagnosis and Management. JH LARAGH, BM BRENNER (eds), Raven Press, New York, 1995, pp 755-773.
43. ESLER M, SKEWS H, LEONARD P, JACKMAN G, BOBIK A, KORNER P: Age-dependence of noradrenaline kinetics in normal subjects. Clin Sci 60: 217-219, 1981.
44. ESLER M, HASTINGS J, LAMBERT G, KAYE D, JENNINGS G, SEALS DR: The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. Am J Physiol 282: R909-R916, 2002.
45. FAROOQI IS, KEOGH JM, YEO GSH, LANK EJ, CHEETHAM T, O'RAHILLY S: Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348: 1085-1095, 2003.
46. FEERO WG, GUTTMACHER AE, COLLINS FS: Genomic medicine - an updated primer. N Engl J Med 362: 2001-2011, 2010.
47. FINCKENBERG P, INKINEN K, AHONEN J, MERASTO S, LOUHELAINEN M, VAPAATALO H, MÜLLER D, GANTEN D, LUFT F, MERVAALA E: Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathway. Am J Pathol 163: 355-366, 2003.
48. FOLKOW B: Physiological aspects of primary hypertension. Physiol Rev 62: 347-504, 1982.
49. FOLKOW B: Hypertensive structural changes in systemic precapillary resistance vessels: how important are they for in vivo haemodynamics. J Hypertens 13: 1546-1559, 1995.
50. FOLKOW B, HALLBÄCK M, LUNDGREN Y, WEISS L: Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta Physiol Scand 80: 93-106, 1970.
51. FRANKENHAEUSER M: Stress. In: The Oxford Companion to the Mind. RL GREGORY (ed), University Press, Oxford, 1987, pp 748-750.
52. FUJITA T, HENRY WL, BARTTER FC, LAKE CR, DELEA CS: Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 69: 334-344, 1980.
53. FUJITA T, ANDO K, OGATA E: Systemic and regional hemodynamics in patients with salt sensitive hypertension. Hypertension 16: 235-244, 1990.
54. GRASSI G: Role of the sympathetic nervous system in human hypertension. J Hypertens 16: 1979-1987, 1998.
55. GRASSI G, SERAVALLE G, CATTANEO BM, BOLLA GB, LAMFRANCHI A, COLOMBO M, GIANNATASIO C, BRUNANI A, CAVAGNINI F, MANCIA G: Sympathetic activation in obese normotensive subjects. Hypertension 25: 560-563, 1995.
56. GREENGARD P: The neurobiology of slow synaptic transmission. Science 294: 1024-1030, 2001.
57. GRIFFITHS AJF, MILLER JH, SUZUKI DT, LEWONTIN RC, GELBART WM: An Introduction to Genetic Analysis. WH Freeman, New York, 2000.
58. GUYTON AC: Arterial Pressure and Hypertension. WB Saunders, Philadelphia, 1980.
59. HADRAVA V, TREMBLAY J, SEKALY RP, HAMET P: Accelerated entry of aortic smooth muscle cells from spontaneously hypertensive rats in the S phase of the cell cycle. Biochem Cell Biol 70: 599-604, 1992.
60. HALL JE, BRANDS MW, HILDEBRANDT DA, MIZELLE HL: Obesity-associated hypertension: hyperinsulinaemia and renal mechanisms. Hypertension 19 (Suppl I): I-45-I-55, 1992.
61. HAMET P, PAUSOVA Z, ADARICHEV V, ADARICHEVA K, TREMBLAY J: Hypertension: genes and environment. J Hypertens 16: 397-418, 1998.
62. HARRAP SB: Causes and effects of high blood pressure: a longitudinal approach to cosegregational analysis. J Cardiovasc Pharmacol 12 (Suppl 3): S99-S109, 1988.
63. HARRAP SB, CUMMING AD, DAVIES DL, FOY CJW, FRASER R, KAMITANI A, CONNOR JM, LEVER AF, WATT GCM: Glomerular hyperfiltration high renin and low extracellular volume in high blood pressure. Hypertension 35: 952-957, 2000.
64. HEAD RJ: Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels 26: 1-20, 1989.
65. HEAD RJ: Hypernoradrenergic innervation and vascular smooth muscle hyperplastic changes. Blood Vessels 28: 173-178, 1991.
66. HOLLENBERG NK, WILLIAMS GH, ADAMS DF: Essential hypertension abnormal renal vascular and endocrine responses to a mild psychological stimulus. Hypertension 3: 11-17, 1981.
67. HUANG BS, WHITE RA, JENG AY, LEENEN FHH: Role of central nervous system aldosterone synthase and mineralocorticoid receptor in salt-induced hypertension in Dahl salt-sensitive rats. Am J Physiol 296: R994-R1000, 2008.
68. HUNT SC, STEPHENSON SH, HOPKINS PN, WILLIAMS RR: Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension 17: 969-976, 1991.
69. HUTCHINS PM, LYNCH CD, COONEY PT, CURSEEN KA: The microcirculation in experimental hypertension and aging. Cardiovasc Res 32: 772-780, 1996.
70. ITO M: The Cerebellum and Neural Control. Raven Press, New York, 1984.
71. ITO M, SAKURAI M, TONGROACH P: Climbing fibre induced depression of both mossy fibre responsiveness and glutamate sensitivity of cerebellar Purkinje cells. J Physiol Lond 324: 113-134, 1982.
72. JENNINGS G, NELSON L, NESTEL P, ESLER M, KORNER P, BURTON D, BAZELMANS J: The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a controlled study of four levels of activity. Circulation 73: 30-40, 1986.
73. JENNINGS GL, DEAKIN G, KORNER P, MEREDITH I, KINGWELL B, NELSON L: What is the dose-response relationship between exercise training and blood pressure. Ann Med 23: 313-318, 1991.
74. JOHNSON RJ, FEIG DI, NAKAGAWA T, SANCHEZ-LOZADA LG, RODRIGUEZ-ITURBE B: Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens 26: 381-391, 2008.
75. JUDY WV, WATANABE AM, MURPHY WR, APRISON BS, YU PL: Sympathetic nerve activity and blood pressure in normotensive backcross rats genetically related to the spontaneously hypertensive rat. Hypertension 1: 598-604, 1979.
76. JULIUS S, VALENTINI M, PALATINI P: Overweight and hypertension: a two way street? Hypertension 35: 807-813, 2000
77. KAHN CR: Causes of insulin resistance. Nature 373: 384-385, 1995.
78. KANDEL ER: The molecular biology of memory storage: a dialogue between genes and synapses. Science 294: 1030-1038, 2001.
79. KANNEL WB, BRAND N, SKINNER JJ, DAWBER TR, MCNAMARA PM: The relation of adiposity to blood pressure and development of hypertension. Ann Intern Med 67: 48-59, 1967.
80. KAPUSCINSKI M, CHARCHAR F, INNES B, MITCHELL GA, NORMAN TL, HARRAP SB: Nerve growth factor gene and hypertension in spontaneously hypertensive rats. J Hypertens 14: 191-197, 1996.
81. KARASEK RA, BAKER D, MARXER F, AHLBOHM A, THEORELL T: Job decision latitude, job demands, and cardiovascular disease: A prospective study in Swedish men. Am J Public Health 75: 694-705, 1981.
82. KINGWELL BA, JENNINGS GL: Effects of walking and other exercise programs upon blood pressure in normal subjects. Med J Aust 158: 234-238, 1993.
83. KISSEBAH AH, KRAKOWER GR: Regional adiposity and morbidity. Physiol Rev 74: 761-811, 1994.
84. KOOLEN MI, VAN BRUMMELEN P: Adrenergic activity and peripheral haemodynamics in relation to sodium sensitivity in patients with essential hypertension. Hypertension 6: 820-825, 1984.
85. KORNER P: Essential Hypertension and Its Causes: Neural and Non-Neural Mechanisms. Oxford University Press, New York, 2007.
86. KORNER PI, ANGUS JA: Structural determinants of vascular resistance properties in hypertension. J Vasc Res 29: 293-312, 1992.
87. KORNER PI, BADOER E, HEAD GA: Cardiovascular role of the major noradrenergic cell groups in the rabbit: analysis based on 6-hydroxydopamine-induced transmitter release. Brain Res 435: 258-272, 1987.
88. KORNER PI, BOBIK A: Cardiovascular development after enalapril in spontaneously hypertensive and Wistar Kyoto rats. Hypertension 25: 610-619, 1995.
89. KORNER PI, BOBIK A, ANGUS JA: Are cardiac and vascular 'amplifiers' both necessary for the development of hypertension? Kidney Int 41 (Suppl 37): S38-S44, 1992
90. KORNER P, BOBIK A, ODDIE C, FRIBERG P: Sympathoadrenal system is critical for structural changes in genetic hypertension. Hypertension 22: 243-252, 1993.
91. KORNER PI, COURTICE FC: The effects of acute anoxia and noradrenaline vasoconstriction on lymph flow and protein dynamics following transfusions of Ringer Locke solution. Aust J Exp Biol Med Sci 32: 321-332, 1954.
92. KORNER PI, HEAD GA: Effects of noradrenergic and serotonergic neurons on blood pressure, heart rate and baroreceptor-heart rate reflex of the conscious rabbit. J Auton Nerv Syst 3: 511-523, 1981.
93. KORNER PI, UTHER JB, WHITE SW: Central nervous integration of the circulatory and respiratory responses to arterial hypoxemia in the rabbit. Circ Res 24: 757-776, 1969.
94. KORNER PI, WRIGHT CE, ANGUS JA: A new approach to assessing the structural total peripheral resistance amplifier in renal (Page) hypertension in conscious rabbits. J Hypertens 28: 1862-1874, 2010.
95. KOSTROMINA EY, RODIONOV IM, SHINKARENKO VS: Tone, autoregulatory properties, and wall thickness-toradius ratio in skeletal muscle arterioles. Am J Physiol 261: H1095-H1101, 1991.
96. KUROKAWA K, FUKAGAWA M, HAYASHI M, SARUTA T: Renal receptors and cellular mechanisms of hormone action in the kidney. In: The Kidney: Physiology and Pathophysiology. DW SELDIN, G GIEBISCH (eds), Raven Press, New York, 1992, pp 1339-1372.
97. LAMBERT GW, VAZ M, RAJKUMAR C, COX HS, TURNER AG, JENNINGS GL, ESLER MD: Cerebral metabolism and its relationship with sympathetic nervous activity in essential hypertension: evaluation of the Dickinson hypothesis. J Hypertens 14: 951-959, 1996.
98. LANDSBERG L: Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 19: 523-528, 2001.
99. LANDSBERG L, YOUNG JB: Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med 298: 1295-1301, 1978.
100. LARAGH JH, BRENNER BM: Hypertension: Pathophysiology, Diagnosis and Management. JH LARAGH, BM BRENNER (eds), Raven Press, New York, 1995.
101. LAW C, BARKER D: Fetal influences on blood pressure. J Hypertens 12: 1329-1332, 1994.
102. LAWLER JE, BARKER GF, HUBBARD JW, SCHAUB RG: Effects of stress on blood pressure and cardiac pathology in rats with borderline hypertension. Hypertension 3: 496-505, 1981.
103. LE MOAL M, SIMON H: Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71: 155-234, 1991.
104. LEE RMK, BORKOWSKI KR, LEENEN FHH, TSOPORIS J, COUGHLIN M: Interaction between sympathetic nervous system and adrenal medulla in the control of cardiovascular changes in hypertension. J Cardiovasc Pharmacol 17 (Suppl 2): S114-S116, 1991.
105. LEENEN FH: The central role of the brain aldosterone-"ouabain" pathway in salt-sensitive hypertension. Biochim Biophys Acta 1082: 1132-1139, 2010.
106. LEENEN FHH, RUZICKA M, HUANG BS: The brain and salt-sensitive hypertension. Curr Hypertens Rep 4: 129-135, 2002.
107. LEIBOWITZ SF: Feeding behavior after hypothalamic 6-hydroxydopamine injections. Appetite 5: 268-271, 1984.
108. LEVI-MONTALCINI R: The nerve growth factor 35 years later. Science 237: 1154-1162, 1987.
109. LIFTON RP: Molecular genetics of human blood pressure variation. Science 272: 676-680, 1996.
110. LIFTON RP, JEUNEMAITRE X: Finding genes that cause human hypertension. J Hypertens 11: 231-236, 1993.
111. LJUNGMAN S, GRANERUS G: The evaluation of kidney function in hypertensive patients. In: Hypertension: Pathophysiology, Diagnosis and Management. JH LARAGH, BM BRENNER (eds), Raven Press, New York, 1995, pp 1987-2004.
112. LUDBROOK J, GRAHAM W: Circulatory responses to onset of exercise: role of arterial and cardiac baroreflexes. Am J Physiol 248: H457-H467, 1985.
113. LUFT FC: Molecular genetics of human hypertension. J Hypertens 16: 1871-1878, 1998.
114. MALENKA R, BEAR M: LTP and LTD: an embarrassment of riches. Neuron 44: 5-21, 2004.
115. MANFREDI AA, ROVERE-QUIRINIA P: The mitochondrion - a Trojan horse that kicks off inflammation? N Engl J Med 362: 2132-2134, 2010
116. MEREDITH IT, JENNINGS GL, ESLER MD, DEWAR EM, BRUCE AM, FAZIO VA, KORNER PI: Time-course of the antihypertensive and autonomic effects of regular endurance exercise in human subjects. J Hypertens 8: 859-866, 1990.
117. MEREDITH IT, FRIBERG P, JENNINGS GL, DEWAR EM, FAZIO VA, LAMBERT GW, ESLER MD: Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 18: 575-582, 1991.
118. MIKI K, YOSHIMOTO M, TANIMIZU M: Acute shifts of baroreflex control of renal sympathetic nerve activity induced by treadmill exercise in rats. J Physiol Lond 548: 313-322, 2003.
119. MO R, OMVIK P, LUND-JOHANSEN P: The Bergen Blood Pressure Study: Offspring of two hypertensive parents have significantly higher blood pressures than offspring of one hypertensive and one normotensive parent. J Hypertens 13: 1614-1617, 1995.
120. MORGAN DA, DIBONA GF, MARK AL: Effects of interstrain renal transplantation on NaCl-induced hypertension in Dahl rats. Hypertension 15: 436-442, 1990.
121. NELSON L, JENNINGS GL, ESLER MD, KORNER PI: Effect of changing levels of physical activity on blood pressure and haemodynamics in essential hypertension. Lancet 2: 473-476, 1986.
122. NILSSON PM, OSTERGREN PO, NYBERG P, SODERSTROM M, ALLEBECK P: Low birth weight is associated with elevated systolic blood pressure in adolescence a prospective study of a birth cohort of 149378 Swedish boys. J Hypertens 15: 1627-1631, 1997.
123. NOBLE D: The Music of Life: Biology Beyond the Genome. Oxford University Press, Oxford, 2006.
124. NORRELUND H, CHRISTENSEN KL, SAMANI NJ, KIMBER P, MULVANY MJ, KORSGAARD N: Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 24: 301-308, 1994.
125. O'ROURKE MF: Arterial Function in Health and Disease. Churchill Livingstone, Edinburgh, 1982.
126. O'ROURKE MF: From theory into practice: arterial haemodynamics in clinical hypertension. J Hypertens 20: 1901-1915, 2002.
127. PICKERING GW: The Nature of Essential Hypertension. J & A Churchill, London, 1961.
128. PICKERING GW: High Blood Pressure. J & A Churchill, London, 1968.
129. PICKERING TG: Psychosocial stress and hypertension: B. Clinical and experimental evidence. In: Textbook of Hypertension. JD SWALES (ed), Blackwell Scientific Publications, Oxford, 1994, pp 640-654.
130. PILOWSKY PM, GOODCHILD AK: Baroreceptor reflex pathways and neurotransmitters: 10 years on. J Hypertens 20: 1675-1688, 2002.
131. POULTER NR, SEVER PS: Low blood pressure populations and the impact of rural-urban migration. In: Textbook of Hypertension. JD SWALES (ed), Blackwell Scientific Publications, Oxford, 1994, pp 22-36.
132. PRAVENEC M, WALLACE C, AITMAN TJ, AND KURTZ TW: Gene expression profiling in hypertension research: a critical perspective. Hypertension 41: 3-8, 2003.
133. PREWITT RL, CHEN IIH, DOWELL R: Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol 243: H243-H251, 1982.
134. RAIZADA MK, FRANCIS SC, WANG H, GELBAND CH, REAVES PY, KATOVICH MJ: Targeting of the reninangiotensin system by antisense gene therapy: a possible strategy for longterm control of hypertension. J Hypertens 18: 353-362, 2000.
135. RAPP JP: Genetic analysis of inherited hypertension in the rat. Physiol Rev 80: 135-172, 2000.
136. REIVICH M, HOLLING H, ROBERTS B, TOOLE JF: Reversal of blood flow through the vertebral artery and its effect on the cerebral circulation. N Engl J Med 265: 878-885, 1961.
137. RETTIG R, GRISK O: The kidney as a determinant of genetic hypertension: evidence from renal transplantation studies. Hypertension 46: 463-468, 2005.
138. RETTIG R, SCHMITT B: Experimental hypertension following kidney transplantation in the rat. In: Handbook of Hypertension, Vol. 16: Experimental and Genetic Models of Hypertension, D GANTEN, W DE JONG (eds), Elsevier, Amsterdam, 1994, pp 141-157.
139. RIZZONI D, PORTERI E, CASTELLANO M, BETTONI G, MUIESAN ML, MUIESAN P, GIULINI SM, AGABITIROSEI E: Vascular hypertrophy and remodelling in secondary hypertension. Hypertension 28: 785-790, 1996.
140. SAFAR ME, PLANTE GE, LONDON GM: Vascular compliance and blood volume in essential hypertension. In: Hypertension: Pathophysiology, Diagnosis and Management. JH LARAGH, BM BRENNER (eds), Raven Press, New York, 1995, pp 377-388.
141. SANDS JM, KOKKO JP, JACOBSON HR: Intrarenal heterogeneity: vascular and tubular. In: The Kidney: Physiology and Pathophysiology. DW SELDIN, G GIEBISCH (eds), Raven Press, New York, 1992, pp 1087-1155.
142. SCHNALL PL, PIEPER C, SCHWARTZ JE, KARASEK R, SCHLUSSEL Y, DEVEREUX R, ALDERMAN M, WARREN K, PICKERING T: The relationship between 'job strain', workplace diastolic blood pressure and left ventricular mass index. JAMA 263: 1929-1935, 1990.
143. 22NaCl by the blood-brain barrier and kidney: its relevance to salt-induced hypertension in Dahl rats. Hypertension 33: 517-523, 1999.
144. SMALLEGANGE C, KLINE RL, ADAMS MA: Transplantation of enalapril-treated kidneys confers persistent lowering of arterial pressure in SHR. Hypertension 42: 932-936, 2003.
145. SOMERS VK, MARK AL, ABBOUD FM: Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension 11: 608-612, 1988.
146. STAESSEN JA, POULTER NR, FLETCHER AE, MARKOWE HL, MARMOT MG, SHIPLEY MJ, BULPITT CJ: Psycho-emotional stress and salt intake may interact to raise BP. J Cardiovasc Risk 1: 45-51, 1994.
147. SUDHIR K, WILSON E, CHATTERJEE K, IVES HE: Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells. J Clin Invest 92: 3003-3007, 1993.
148. SULLIVAN JM: Salt sensitivity: definition, conception, methodology, and long-term issues. Hypertension 17 (Suppl I): I61-I68, 1991.
149. SWALES JD: Textbook of Hypertension. Blackwell Scientific Publications, Oxford, 1994.
150. TACK CJ, LUTTERMAN JA, VERWOORT G, THIEN T, SMITS P: Activation of the sodium-potassium pump contributes to insulin-induced vasodilatation in humans. Hypertension 28: 426-432, 1996.
151. TARAZI RC, FROHLICH ED, DUSTAN HP: Plasma volume in men with essential hypertension. N Engl J Med 278: 762-765, 1968.
152. THOENEN H, BARDE Y-A: Physiology of nerve growth factor. Physiol Rev 60: 1284-1335, 1980.
153. THORBURN GD, HARDING RE: Textbook of Fetal Physiology. Oxford University Press, Oxford, 1994.
154. THORNBURG KL, MORTON MJ: Development of the cardiovascular system. In: Textbook of Fetal Physiology. GD THORBURN, R HARDING (eds), Oxford Medical Publications, Oxford, 1994, pp 95-130.
155. TIMIO M, LIPPI G, VENANZI S, GENTILI S, QUINTALIANI G, VERDURA C, MONARCA C, SARONIO P, TIMIO F: Blood pressure trend and cardiovascular events in nuns in a secluded order: a 30 year follow-up study. Blood Press 6: 81-87, 1997.
156. TIPTON CM, MATTHES RD, MARCUS KD, ROWLETT KA, LEININGER JR: Influences of exercise intensity, age, and medication on resting systolic blood pressure of SHR populations. J Appl Physiol 55: 1305-1310, 1983.
157. TIPTON CM, STUREK MS, OPPLIGER RA, MATTHES RD, OVERTON JM, EDWARDS JB: Responses of SHR to combinations of chemical sympathectomy, adrenal demedullation and training. Am J Physiol 247: H109-H118, 1984.
158. TUCK ML: Obesity. In: Textbook of Hypertension, JD SWALES (ed), Blackwell Scientific Publications, Oxford, 1994, pp 576-592.
159. ULRYCH M, HOFMAN J, HEJL Z: Cardiac and renal hyperresponsiveness to acute plasma volume expansion in hypertension. Am Heart J 68: 193-203, 1971.
160. VAN DEN BUUSE M, VERSTEEG DH, DE JONG W: Role of dopamine in the development of spontaneous hypertension. Hypertension 6: 899-905, 1984.
161. VARMUS H: Ten years on - the human genome and medicine. N Engl J Med 362: 2028-2029, 2010.
162. VENTER JC: Multiple personal genomes await. Nature 464: 676-677, 2010.
163. WARD R: Familial aggregation and genetic epidemiology of blood pressure. In: Hypertension: Pathophysiology, Diagnosis and Management. JH LARAGH, BM BRENNER (eds), Raven Press, New York, 1995, pp 67-88.
164. ZHANG Q, RAOOF M, CHEN Y, SUMI Y, SURSAL T, JUNGER W, BROHI K, ITAGAKI K, HAUSER CJ: Circulating mitochondrial DAMPs cause inflammatory response to injury. Nature 464: 104-108, 2010.
165. ZICHA J, KUNEŠ J: Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Rev 79: 1227-1282, 1999.